Interv Akut Kardiol. 2018;17(3):164-168 | DOI: 10.36290/kar.2018.010

Timing surgery in mitral regurgitation: defining risk using stress echocardiography

Martin Troubil
Kardiochirurgická klinika, Fakultní nemocnice Olomouc

Mitral regurgitation (MR) is the second most common valvular disease requiring surgery. Proper identification of surgical candidatesand optimising the timing of surgery are key in management. For primary MR, this relies upon a balance between theperi-operative risks and rates of successful repair in patients undergoing early surgery when asymptomatic with the potentialrisk of irreversible left ventricular dysfunction if intervention is delayed. For secondary MR, recognition that this is a highly dynamiccondition where MR severity may change is key, although data on outcomes in determining whether concomitant valveintervention is performed with revascularisation has raised questions regarding timing of surgery. There has been substantialinterest in the use of stress echocardiography to risk stratify patients in mitral regurgitation. This article reviews the role of stressechocardiography in both primary and secondary mitral regurgitation.

Keywords: stress echocardiography, primary mitral regurgitation, secondary mitral regurgitation

Received: May 10, 2018; Accepted: June 2, 2018; Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Troubil M. Timing surgery in mitral regurgitation: defining risk using stress echocardiography. Interv Akut Kardiol. 2018;17(3):164-168. doi: 10.36290/kar.2018.010.
Download citation

References

  1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24(13): 1231-1243. Go to original source... Go to PubMed...
  2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368(9540): 1005-1011. Go to original source... Go to PubMed...
  3. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications Circulation. 1999; 99(3): 400-405. Go to original source... Go to PubMed...
  4. Quintana E, Suri RM, Thalji NM, et al. Left ventricular dysfunction after mitral valve repair-the fallacy of "normal" preoperative myocardial function. J Thorac Cardiovasc Surg. 2014; 148(6): 2752-2760. Go to original source... Go to PubMed...
  5. Falk V, Baumgartner H, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2017; 52(4): 616-664. Go to original source... Go to PubMed...
  6. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012; 33(19): 2451-2496. Go to original source... Go to PubMed...
  7. Enriquez-Sarano M, Suri RM, Clavel MA, et al. Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation. J Thorac Cardiovasc Surg. 2015; 150(1): 50-58. Go to original source... Go to PubMed...
  8. David TE, Armstrong S, McCrindle BW, Manlhiot C. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation. 2013; 127(14): 1485-1492. Go to original source... Go to PubMed...
  9. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation. 1994; 90(2): 830-837. Go to original source... Go to PubMed...
  10. Tribouilloy C, Grigioni F, Avierinos JF, et al. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol. 2009; 54(21): 1961-1968. Go to original source... Go to PubMed...
  11. Detaint D, Sundt TM, Nkomo VT, et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation 2006; 114(4): 265-272. Go to original source... Go to PubMed...
  12. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet 2009; 373(9672): 1382-1394. Go to original source... Go to PubMed...
  13. LaPar DJ, Ailawadi G, Isbell JM, et al. Mitral valve repair rates correlate with surgeon and institutional experience. J Thorac Cardiovasc Surg. 2014; 148(3): 995-1003; discussion - 4. Go to original source... Go to PubMed...
  14. Kang DH, Park SJ, Sun BJ, et al. Early surgery versus conventional treatment for asymptomatic severe mitral regurgitation: a propensity analysis. J Am Coll Cardiol 2014; 63(22): 2398-2407. Go to original source... Go to PubMed...
  15. Bolling SF, Li S, O'Brien SM, Brennan JM, Prager RL, Gammie JS. Predictors of mitral valve repair: clinical and surgeon factors. Ann Thorac Surg. 2010; 90(6): 1904-1911; discussion 12. Go to original source... Go to PubMed...
  16. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 2006; 113(18): 2238-2244. Go to original source... Go to PubMed...
  17. Suri RM, Clavel MA, Schaff HV, et al. Effect of recurrent mitral regurgitation following degenerative mitral valve repair: long-term analysis of competing outcomes. J Am Coll Cardiol. 2016; 67(5): 488-498. Go to original source... Go to PubMed...
  18. Grigioni F, Avierinos JF, Ling LH, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol. 2002; 40(1): 84-92. Go to original source... Go to PubMed...
  19. Le Tourneau T, Messika-Zeitoun D, Russo A, et al. Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol. 2010; 56(7): 570-578. Go to original source... Go to PubMed...
  20. Supino PG, Borer JS, Schuleri K, et al. Prognostic value of exercise tolerance testing in asymptomatic chronic nonischemic mitral regurgitation. Am J Cardiol. 2007; 100(8): 1274-1281. Go to original source... Go to PubMed...
  21. Messika-Zeitoun D, Johnson BD, Nkomo V, et al. Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications. J Am Coll Cardiol. 2006; 47(12): 2521-2527. Go to original source... Go to PubMed...
  22. Magne J, Lancellotti P, Pierard LA. Exercise-induced changes in degenerative mitral regurgitation. J Am Coll Cardiol. 2010; 56(4): 300-309. Go to original source... Go to PubMed...
  23. Magne J, Donal E, Mahjoub H, et al. Impact of exercise pulmonary hypertension on postoperative outcome in primary mitral regurgitation. Heart 2015; 101(5): 391-396. Go to original source... Go to PubMed...
  24. Agricola E, Galderisi M, Oppizzi M, et al. Pulsed tissue Doppler imaging detects early myocardial dysfunction in asymptomatic patients with severe mitral regurgitation. Heart 2004; 90(4): 406-410. Go to original source... Go to PubMed...
  25. Magne J, Mahjoub H, Pierard LA, et al. Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation. Heart 2012; 98(7): 584-591. Go to original source... Go to PubMed...
  26. Lee R, Haluska B, Leung DY, Case C, Mundy J, Marwick TH. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart 2005; 91(11): 1407-1412. Go to original source... Go to PubMed...
  27. Lancellotti P, Lebrun F, Pierard LA. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2003; 42(11): 1921-1928. Go to original source... Go to PubMed...
  28. Lancellotti P, Gerard PL, Pierard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J. 2005; 26(15): 1528-1532. Go to original source... Go to PubMed...
  29. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001; 103(13): 1759-1764. Go to original source... Go to PubMed...
  30. Michler RE, Smith PK, Parides MK, et al. Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. N Engl J Med. 2016; 374(20): 1932-1941. Go to original source... Go to PubMed...
  31. Chan KM, Punjabi PP, Flather M, et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation 2012; 126(21): 2502-2510. Go to original source... Go to PubMed...
  32. Fattouch K, Guccione F, Sampognaro R, et al. POINT: efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009; 138(2): 278-285. Go to original source... Go to PubMed...
  33. Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016; 374(4): 344-353. Go to original source... Go to PubMed...
  34. Lancellotti P, Magne J, Dulgheru R, Ancion A, Martinez C, Pierard LA. Clinical significance of exercise pulmonary hypertension in secondary mitral regurgitation. Am J Cardiol. 2015; 115(10): 1454-1461. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.